These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 2337058)

  • 1. Four-hour measurement of urinary iron excretion after deferoxine treatment: a rapid, simple method for study of iron excretion.
    Bonkovsky HL; Weber R; Aaron L
    Am J Gastroenterol; 1990 May; 85(5):554-7. PubMed ID: 2337058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Post-desferrioxamine urinary iron in iron-overload states].
    Santiago Corchado M; Ribas Ozonas B
    Rev Clin Esp; 1970 Jul; 118(2):151-8. PubMed ID: 5486372
    [No Abstract]   [Full Text] [Related]  

  • 3. Assessment of liver iron content in 271 patients: a reevaluation of direct and indirect methods.
    Brissot P; Bourel M; Herry D; Verger JP; Messner M; Beaumont C; Regnouard F; Ferrand B; Simon M
    Gastroenterology; 1981 Mar; 80(3):557-65. PubMed ID: 7450446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased urinary excretion of 8-iso-prostaglandin F2alpha in patients with HFE-related hemochromatosis: a case-control study.
    Kom GD; Schwedhelm E; Nielsen P; Böger RH
    Free Radic Biol Med; 2006 Apr; 40(7):1194-200. PubMed ID: 16545687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of two years of deferoxamine therapy on iron balance, ferritin, liver and heart in patients with thalassemia major].
    Flückiger A; Imbach P; Pfenninger E; Stocker F; Töndury P; Wagner HP; Weber J; Zuppinger K
    Helv Paediatr Acta; 1985 Sep; 40(4):293-304. PubMed ID: 4077563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of ascorbic acid on desferrioxamine-induced urinary iron excretion in idiopathic hemochromatosis.
    Conte D; Brunelli L; Ferrario L; Mandelli C; Quatrini M; Velio P; Bianchi PA
    Acta Haematol; 1984; 72(2):117-20. PubMed ID: 6437113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New diagnostic and therapeutic possibilities in manifest idiopathic hemochromatosis.
    Volkholz HJ; Sailer D; Rödl W
    Hepatogastroenterology; 1984 Dec; 31(6):289-94. PubMed ID: 6519641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term intraperitoneal deferoxamine for hemochromatosis.
    Swartz RD; Legault DJ
    Am J Med; 1996 Mar; 100(3):308-12. PubMed ID: 8629676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of subcutaneous deferoxamine and oral vitamin C on iron excretion in congenital hypoplastic anemia and refractory anemia associated with the 5q-syndrome.
    Ambruso DR; Mahony BS; Githens JH; Rhoades ED
    Am J Pediatr Hematol Oncol; 1982; 4(2):115-23. PubMed ID: 7114394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of desferrioxamine-induced sideruria and measurement of labile iron store as indices of body iron status.
    Singh AK
    J Med; 1971; 2(6):345-62. PubMed ID: 5292126
    [No Abstract]   [Full Text] [Related]  

  • 11. Hepatic iron concentration in hereditary hemochromatosis does not saturate or accurately predict phlebotomy requirements.
    Olynyk JK; Luxon BA; Britton RS; Bacon BR
    Am J Gastroenterol; 1998 Mar; 93(3):346-50. PubMed ID: 9517637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of hepatic iron overload in thalassemic patients by magnetic resonance spectroscopy.
    Dixon RM; Styles P; al-Refaie FN; Kemp GJ; Donohue SM; Wonke B; Hoffbrand AV; Radda GK; Rajagopalan B
    Hepatology; 1994 Apr; 19(4):904-10. PubMed ID: 8138264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Respective variations of iron in blood and urine in cirrhotic and alcoholic patients after a desferrioxamine test].
    Aron E; Weill JD; Galand A; Domenech
    Arch Fr Mal App Dig; 1966 Dec; 55(12):1159-66. PubMed ID: 5986599
    [No Abstract]   [Full Text] [Related]  

  • 14. Iron mobilisation with chelating agents during acute viral hepatitis.
    Hengeveld P; Zuyderhoudt FM
    Hepatogastroenterology; 1982 Oct; 29(5):191-4. PubMed ID: 7173806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic accuracy of the urinary albumin: creatinine ratio determined by the CLINITEK Microalbumin and DCA 2000+ for the rule-out of albuminuria in chronic kidney disease.
    Guy M; Newall R; Borzomato J; Kalra PA; Price C
    Clin Chim Acta; 2009 Jan; 399(1-2):54-8. PubMed ID: 18834870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subcutaneous bolus injection of deferoxamine in adult patients affected by onco-hematologic diseases and iron overload.
    Borgna-Pignatti C; Franchini M; Gandini G; Vassanelli A; De Gironcoli M; Aprili G
    Haematologica; 1998 Sep; 83(9):788-90. PubMed ID: 9825575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary zinc excretion and zinc status of patients with beta-thalassemia major.
    Aydinok Y; Coker C; Kavakli K; Polat A; Nisli G; Cetiner N; Kantar M; Cetingül N
    Biol Trace Elem Res; 1999 Nov; 70(2):165-72. PubMed ID: 10535525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of 14C-urinary excretion and its comparison with 14CO2 in breath after 14C-urea administration in Helicobacter pylori infection.
    Pathak CM; Bhasin DK; Panigrahi D; Goel RC
    Am J Gastroenterol; 1994 May; 89(5):734-8. PubMed ID: 8172148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Iron-overload in patients on maintenance hemodialysis: diagnostic criteria, indications and treatment by desferrioxamine (author's transl)].
    Simon P; Bonn F; Guezennec M; Tanquerel T; Ksang
    Nephrologie; 1981; 2(4):165-70. PubMed ID: 7329501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anemia of inflammatory disease in the dog: availability of storage iron in inflammatory disease.
    Feldman BF; Kaneko JJ; Farver TB
    Am J Vet Res; 1981 Apr; 42(4):586-9. PubMed ID: 7332116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.